281234-68-2

Basic information

• Product Name: Benzoic acid, 4-(1-oxido-2-pyridinyl)-
• CAS NO: 281234-68-2
• Molecular Formula: C12H9NO3
• Molecular Weight: 215.208
• Mol File: 281234-68-2.mol
• Article Data: 10

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 4-(1-oxido-2-pyridinyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 4-(1-oxido-2-pyridinyl)-(281234-68-2)
• EPA Substance Registry System: Benzoic acid, 4-(1-oxido-2-pyridinyl)-(281234-68-2)

Safety Data

• Hazardous Substances Data: 281234-68-2(Hazardous Substances Data)

Upstream product

• 694-59-7 pyridine N-oxide 
• 14047-29-1 4-carboxyphenylboronic acid 
• 80866-91-7 2-bromopyridine-N-oxide hydrochloride 
• 4385-62-0 4-(pyridin-2-yl)benzoic acid 
• 102676-38-0 2-<4-(ethoxycarbonyl)phenyl>pyridine N-oxide 

Downstream Products

• 370863-44-8 3-{1-[4-(1-Oxypyridin-2-yl)-benzoyl]-1,2,3,6-tetrahydropyridin-4 yl}benzamidine trifluoroacetate 

Relevant articles and documents

Palladium-catalyzed direct C-H arylation of pyridine N-oxides with potassium aryl- and heteroaryltrifluoroborates

An efficient ligand-free Pd(OAc)2-catalyzed selective arylation of pyridine N-oxides using potassium (hetero)aryltrifluoroborates as coupling partners via C-H bond activation was achieved in the presence of TBAI. This approach has a broad subst

Diamine derivatives

A compound represented by the general formula (1): Q1-Q2-T0-N(R1)-Q3-N(R2)-T1-Q4??(1) wherein R1 and R2 are hydrogen atoms or the like; Q1 is a saturated or unsaturated, 5- or 6-membered cyclic hydrocarbon group which may be substituted, or the like; Q2 is a single bond or the like; Q3 is a group in which Q5 is an alkylene group having 1 to 8 carbon atoms, or the like; and T0 and T1 are carbonyl groups or the like; a salt thereof, a solvate thereof, or an N-oxide thereof. The compound is useful as an agent for preventing and/or treating cerebral infarction, cerebral embolism, myocardial infarction, angina pectoris, pulmonary infarction, pulmonary embolism, Buerger's disease, deep venous thrombosis, disseminated intravascular coagulation syndrome, thrombus formation after valve or joint replacement, thrombus formation and reocclusion after angioplasty, systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), thrombus formation during extracorporeal circulation, or blood clotting upon blood drawing.

DIAMINE DERIVATIVES

A compound represented by the general formula (1):Q1-Q2-T0-N(R1)-Q3-N(R2)-T1-Q4 wherein R1 and R2 are hydrogen atoms or the like; Q1 is a saturated or unsaturated, 5- or 6- membered cyclic hydrocarbon group which may be substituted, or the like; Q2 is a single bond or the like; Q3 is a group in which Q5 is an alkylene group having 1 to 8 carbon atoms, or the like; and T0 and T1 are carbonyl groups or the like; a salt thereof, a solvate thereof, or an N-oxide thereof. The compound is useful as an agent for preventing and/or treating cerebral infarction, cerebral embolism, myocardial infarction, angina pectoris, pulmonary infarction, pulmonary embolism, Buerger's disease, deep venous thrombosis, disseminated intravascular coagulation syndrome, thrombus formation after valve or joint replacement, thrombus formation and reocclusion after angioplasty, systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), thrombus formation during extracorporeal circulation, or blood clotting upon blood drawing.